← Leaderboards
Adam Snook
Lehigh University
$401,369
Attributed
$802,738
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $218.8K · FY2022–25$250K$187.5K$125K$62.5K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$802,738 · 2
By mechanism
R21$802,738 · 2
Top collaborators
- Sangwon Vincent Kim2 shared
- Damien Thevenin2 shared
Most similar at Lehigh University
Same institution · by research overlap
- Damien Thevenin$2,380,406
- George J Dupaul$5,667,583
Others in their field
Other Rising Stars on “Infiltration”
- Jeff T Hutchins · Inhalon Biopharma, Inc.$6,140,875
- Kenneth Schultz · Trethera Corporation$4,051,620
- David G Brooks · Boston Immune Technologies And Therapeutics, Inc.$3,974,764
- Justin Lee Grodin · Ut Southwestern Medical Center$3,560,217
- Ioannis Vlachos · Beth Israel Deaconess Medical Center$3,412,120
- Kathryn Marie Jones · Baylor College Of Medicine$3,103,804
Research focus
InfiltrationMalignant NeoplasmsLaboratoriesTissuesTumorRecruitT-LymphocyteIn VitroPeripheral BloodSolid NeoplasmAnimal ModelToxic EffectCancer TypeSafetyIn VivoCellsEngineeringCar T Cell TherapyChimeric Antigen Receptor T CellsBiological MarkersBaseAntibodiesAutologousAutoimmune Responses
Grant awards (4)
Ligand-Induced Recruitment of CAR-T Cells to Colorectal Cancers$182,325
R21 · FY2025 · CA · contact PI
Ligand-Induced Recruitment of CAR-T Cells to Colorectal Cancers$218,790
R21 · FY2024 · CA · contact PI
Off-the-shelf CAR-T Therapy via Tumor-Selective Immuno-engagers$209,722
R21 · FY2023 · CA
Off-the-shelf CAR-T Therapy via Tumor-Selective Immuno-engagers$191,901
R21 · FY2022 · CA